<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04872699</url>
  </required_header>
  <id_info>
    <org_study_id>SPEED-COVID19</org_study_id>
    <nct_id>NCT04872699</nct_id>
  </id_info>
  <brief_title>Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study</brief_title>
  <acronym>SPEED-COVID</acronym>
  <official_title>Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Sud Essonne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Sud Essonne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the prevalence of COVID-19 among the residents and&#xD;
      geriatric inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a&#xD;
      general hospital located in Ile-de-France, France), and the factors that are likely to&#xD;
      influence this prevalence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Among people exposed to the COVID-19 (SARS-COV-2) pandemic, elderly people are considered as&#xD;
      particularly vulnerable, especially those living in nursing homes or hospitalized.&#xD;
      Furthermore, facilities / accommodations are registered among the main locations of COVID-19&#xD;
      clusters.&#xD;
&#xD;
      These observations have led the French government to establish specific protection measures&#xD;
      and survey dependent care facilities for the elderly and long-term care units in the&#xD;
      hospital.&#xD;
&#xD;
      With these new standards established, a long-term study of all the residents and geriatric&#xD;
      inpatients of the care facilities attached to the Centre Hospitalier Sud Essonne (a general&#xD;
      hospital located in Ile-de-France, France), can provide additional knowledge on COVID-19.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 22, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>General prevalence of COVID-19</measure>
    <time_frame>Through the study completion, an average of 12 months</time_frame>
    <description>measures the prevalence of COVID-19 among the residents and geriatric inpatients, defined as resident and patients with positive serologic or RT-PCR test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of asymptomatic residents/inpatients</measure>
    <time_frame>Through study completion, an average of 12 months</time_frame>
    <description>no RT-PCR test or negative RT-PCR test and positive serologic test,&#xD;
positive RT PCR and no symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of symptomatic residents/inpatients</measure>
    <time_frame>Through study completion, an average of 12 months</time_frame>
    <description>Positive RT-PCR test or serologic test with symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of residents/inpatients with severe form of COVID-19 which led to an hospitalization</measure>
    <time_frame>Through study completion, an average of 12 months</time_frame>
    <description>Positive RT-PCR test or serologic test and hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of residents/inpatients infected with COVID-19 and hospitalized in a critical care unit</measure>
    <time_frame>Through study completion, an average of 12 months</time_frame>
    <description>Positive RT-PCR test or serologic test and hospitalization in critical care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of residents/inpatients infected with COVID-19 and deceased</measure>
    <time_frame>Through study completion, an average of 12 months</time_frame>
    <description>Positive RT-PCR test or serologic test and deceased</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of residents/inpatients vaccinated against COVID-19</measure>
    <time_frame>Through study completion, an average of 12 months</time_frame>
    <description>Positive RT-PCR test or serologic test and vaccinated with any authorized vaccine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influencing factors of the prevalence of COVID-19 among residents/inpatients</measure>
    <time_frame>Through study completion, an average of 12 months</time_frame>
    <description>age&#xD;
sex&#xD;
comorbidities&#xD;
the context of the infection with COVID-19&#xD;
vaccinated or not</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serology testing, RT PCR</intervention_name>
    <description>Periodic testings and testings with characteristic symptoms occur</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Residents and geriatric inpatients of the care facilities attached to the Centre&#xD;
        Hospitalier Sud Essonne (a general hospital located in Ile-de-France, France), from march,&#xD;
        2020, to december, 2021, who are not opposed to participate in this study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  residents of the dependant care facility for the elderly&#xD;
&#xD;
          -  inpatients of the long-term care unit&#xD;
&#xD;
          -  from march, 2020 to december, 2021&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  opposition to participate in this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shidasp SIAMI, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Sud Essonne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shidasp SIAMI, MD, PhD</last_name>
    <phone>0033 1 60 80 79 40</phone>
    <email>ssiami@ch-sudessonne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Delphine LEMAIRE-BRUNEL</last_name>
    <phone>0033 1 60 80 79 88</phone>
    <email>dlemaire-brunel@ch-sudessonne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Sud Essonne</name>
      <address>
        <city>Ã‰tampes</city>
        <state>Essonne</state>
        <zip>91150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine LEMAIRE-BRUNEL</last_name>
      <phone>0033 1 60 80 79 88</phone>
      <email>dlemaire-brunel@ch-sudessonne.fr</email>
    </contact>
    <investigator>
      <last_name>Shidasp SIAMI, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hafida BENHABIB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christine ANDREO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>El Hadi EL GHOUATI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurence SAINSARD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christelle APARICIO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 2, 2021</study_first_submitted>
  <study_first_submitted_qc>May 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2021</study_first_posted>
  <last_update_submitted>May 2, 2021</last_update_submitted>
  <last_update_submitted_qc>May 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>elderly</keyword>
  <keyword>COVID</keyword>
  <keyword>SARS-COV-2</keyword>
  <keyword>prevalence</keyword>
  <keyword>dependant care</keyword>
  <keyword>long-term unit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

